|
| |
| | | 68441 | | 09.06.2022 | | Novartis Pharma Schweiz AG | | | | | | | 08.06.2027 | | | | | | 07.16.10. | | | | 07.16. | | FI |
| | Seq.-Nr. | Präparat | Beschreibung | Galenische Form | ATC-Klassierung | |
|---|
| 01 | Scemblix 20 mg | Filmtabletten | Filmtabletten (Asciminibum 20 mg) | L01EA06 | PI | | 02 | Scemblix 40 mg | Filmtabletten | Filmtabletten (Asciminibum 40 mg) | L01EA06 | PI | | 03 | Scemblix 100 mg | Filmtabletten | Filmtabletten (Asciminibum 100 mg) | L01EA06 | PI |
|
|
|
